Trial intelligence / Profile preview

Collagenase (Xiapex) for Dupuytren's disease of the thumb and first webspace

NL-OMON27401Not yet recruiting

Sponsor
Prof P.M.N.Werker P.O.Box 30001 9700RB Groningen +31503618840 [email protected]
Start
Apr 2012
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Prof P.M.N.Werker P.O.Box 30001 9700RB Groningen +31503618840 [email protected]. Primary endpoint: Correction of extension deficit. Planned start Apr 2012; status: not yet recruiting.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren's contracture

Beyond the preview

Go deeper on NL-OMON27401.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON27401.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call